Evergreen Talk Series: Clinical Considerations for Linagliptin and its combinations with Metformin, Dapagliflozin MD Brand Connect2 Jan 2024 11:00 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
The addition of salt causes increased risk of chronic kidney disease Anshika Mishra2 Jan 2024 9:15 AM ISTIn a groundbreaking study researchers from the U.S.A reported the effect of adding salt to foods on chronic kidney disease. They found that increased...
Microbiome changes linked to Kidney stone formation Anshika Mishra28 Dec 2023 9:15 AM ISTA recent study by Lawson Health Research Institute and Western University, published in the journal Microbiome, has unveiled a significant link...
Palliative care is underused for patients with malignant urinary obstruction Anshika Mishra25 Dec 2023 9:15 AM ISTLess than half of patients with malignant ureteral obstruction (MUO)-a serious complication of advanced cancer, with a poor prognosis-receive...
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
Outsize benefit seen in trial of drug for kidney disease Roshni Dhar18 Dec 2023 6:15 PM ISTIn a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria-albumin in urine, a sign of kidney...
Clinical trial proves that the ketogenic diet is effective at controlling polycystic kidney disease Preksha garg14 Dec 2023 9:00 AM ISTThe ketogenic diet proved to be effective at controlling polycystic kidney disease (PKD) in the first randomized controlled clinical trial of...
Study reveals insights into tacking diabetic kidney disease - with a side order of how anti-obesity drugs work Roshni Dhar13 Dec 2023 9:30 AM ISTData from Australian researchers could partly explain why a trial of a new drug for diabetes, was recently halted because it was found to be so...
Evergreen Talk Series: Clinical applicability of Linagliptin in T2DM across CKD spectrum and Dapagliflozin up to CKD stage 4 MD Brand Connect1 Dec 2023 11:17 AM IST Advertisement Presenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and...
Evergreen Talk Series: Clinical Benefits of Linagliptin and Dapagliflozin Combination in Type 2 Diabetes Management MD Brand Connect10 Nov 2023 11:54 AM IST Advertisement Presenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a...
